Cancer TPCA-1 in vivo Epidemiol Biomarkers Prev 2005, 14:1998–2003.PubMedCrossRef 21. Jerevall PL, Ahmadi A, Bergman M, Stal O, Wingren S: Sulfotransferase1A1 and risk of postmenopausal breast cancer. Anticancer Res 2005, 25:2515–2517.PubMed 22. Choi JY, Lee KM, Park SK, Noh DY, Ahn SH, Chung HW, Han W, Kim JS, Shin SG, Jang IJ, Yoo KY, Hirvonen A, Kang D: Genetic polymorphisms of SULT1A1 and SULT1E1 and the risk and survival of breast cancer. Cancer Epidemiol Biomarkers Prev 2005, 14:1090–1095.PubMedCrossRef 23. Cheng TC, Chen ST, Huang CS, Fu YP,
Yu JC, Cheng CW, Wu PE, Shen CY: Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: a multigenic study on cancer susceptibility. Int J Cancer 2005, 113:345–353.PubMedCrossRef 24. Langsenlehner U, Krippl P, Renner W, Yazdani-Biuki B, Eder T, Wolf G, Wascher TC, Paulweber B, Weitzer W, Samonigg H: Genetic variants of the sulfotransferase 1A1 and breast cancer risk. Breast Cancer Res Treat 2004, 87:19–22.PubMedCrossRef 25.
Han DF, Zhou X, Hu MB, Wang CH, Xie W, Tan XD, Zheng F, Liu F: Sulfotransferase 1A1 (SULT1A1) polymorphism and breast cancer risk in Chinese women. Toxicol Lett 2004, 150:167–177.PubMedCrossRef 26. Chacko P, Rajan B, Mathew BS, Joseph T, Pillai MR: CYP17 and SULT1A1 gene polymorphisms in Indian breast cancer. Breast Cancer 2004, 11:380–388.PubMedCrossRef Temozolomide datasheet 27. Tang DL, Rundle A, Mooney L, Cho S, Schnabel F, Estabrook A, Kelly A, Levine R, Hibshoosh H, Perera F: Sulfotransferase 1A1 (SULT1A1) polymorphism, PAH-DNA adduct levels in breast tissue and breast cancer risk in a case-control study. Breast Cancer Res Tr 2003, 78:217–222.CrossRef 28. Zheng W, Xie DW, Cerhan JR, Sellers TA, Wen WQ, Folsom AR: Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure, well-done
meat intake, and breast cancer risk. Cancer Epidem Biomar 2001, 10:89–94. 29. Seth P, Lunetta KL, Bell DW, Gray H, Nasser SM, Rhei E, Kaelin CM, Iglehart DJ, Marks JR, Garber JE, Haber DA, Polyak K: Phenol sulfotransferases: Hormonal regulation, polymorphism, and age of onset of breast cancer. Cancer Res 2000, 60:6859–6863.PubMed 30. Tau-protein kinase The MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk: Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women. Breast Cancer Res Treat 2010, 119:463–474.CrossRef 31. Kim KA, Lee SY, Park PW, Ha JM, Park JY: Genetic polymorphisms and linkage disequilibrium of sulfotransferase SULT1A1 and SULT1A2 in a Korean population: comparison of other ethnic groups. Eur J Clin Pharmacol 2005, 61:743–747.PubMedCrossRef 32. Pasqualini JR: The selective estrogen enzyme modulators in breast cancer: a https://www.selleckchem.com/products/z-vad(oh)-fmk.html review. Biochim Biophys Acta 2004, 1654:123–143.PubMed 33.